SEP 14, 2017 09:00 AM PDT

Development of tools enabling tunable, in situ delivery of therapeutics using probiotics

C.E. CREDITS: P.A.C.E. CE | Florida CE
Speakers
  • Postdoctoral Research Scholar , Washington University School of Medicine
    Biography
      Nathan Crook is a postdoctoral researcher in the Department of Pathology & Immunology at Washington University School of Medicine in the laboratory of Prof. Gautam Dantas, where he is applying functional metagenomics and next-generation sequencing to improve control over colonization and gene expression in probiotic bacteria. Nathan received his B.S. in Chemical Engineering from the California Institute of Technology in 2009, and his PhD in Chemical Engineering from the University of Texas at Austin in 2014. During his graduate work in the Alper Lab, Nathan developed several high-throughput computational and experimental methods which accelerate the engineering of new industrial phenotypes in S. cerevisiae. In the future, Nathan aims to engineer probiotics for in situ synthesis and delivery of therapeutics. Nathan has published 10 papers relating to his work, in addition to 2 book chapters and 3 review articles. He has mentored 2 high school students, 6 undergraduates, and 4 graduate students in experimental synthetic biology research. Nathan received the National Science Foundation's Graduate Research Fellowship in 2010.

    Abstract:

    The human large intestine houses trillions of microorganisms which collectively form the highly diverse microbial community known as the gut microbiota. The gut microbiota performs many functions critical to the maintenance of health, including extraction of nutrients from food, production of vitamins, and defense against pathogens. Like an organ, disturbances to the structure of the gut microbiota can have significant negative impacts to the human host, including obesity, malnutrition, and cancer. However, the gut microbiota is currently unique among organs in that it is highly engineerable, enabling improvement of function by substituting beneficial microbes for less desirable ones. These exogenous beneficial microbes are termed “probiotics” and their close contact with both their human host, as well as other gut bacteria, raises exciting therapeutic prospects, including the provision of additional metabolic functions, modulation of the host immune response, or competitive exclusion of pathogens. However, these applications remain out of reach due to the low residence time of most probiotics within the gut, as well as an inability to reliably control gene expression in probiotics residing in the gut environment.  In this talk, I will show exciting data from a culture-independent bioprospecting approach for increasing the residence time and altering the biogeography of probiotic strains within the gut. Then, I will discuss the optimization and application of a high-throughput sequencing-based approach to the parallel characterization of many transcriptional regulators in gut-resident probiotics. Taken together, this work has the potential to significantly improve our understanding and use of probiotics while providing a framework for developing robust chassis strains for future synthetic biology efforts in the human gut microbiota.


    Show Resources
    You May Also Like
    SEP 05, 2019 04:00 PM CEST
    C.E. CREDITS
    SEP 05, 2019 04:00 PM CEST
    DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
    JUN 05, 2019 05:00 PM CEST
    C.E. CREDITS
    JUN 05, 2019 05:00 PM CEST
    DATE: June 5, 2019TIME: 8:00am PDT, 11:00am EDT, 5:00pm CEST Eukaryotic cell cultures respond to the most subtle influence. Apart from the risk of contamination, minimal chan...
    MAY 16, 2019 04:00 PM CEST
    C.E. CREDITS
    MAY 16, 2019 04:00 PM CEST
    DATE: May 16, 2019TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST The emergence of NGS is revolutionizing the microbiological sciences and transforming medicine. Deep sequencing has...
    OCT 02, 2019 11:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    OCT 02, 2019 11:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: October 2, 2019TIME: 11:00am PDT, 2:00pm EDT Ditch the Excel spreadsheets and manage your molecular workflows entirely in your LIMS Achieve configuration of molecular workf...
    AUG 27, 2019 09:00 AM PDT
    C.E. CREDITS
    AUG 27, 2019 09:00 AM PDT
    DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
    MAR 26, 2019 02:00 PM PDT
    C.E. CREDITS
    MAR 26, 2019 02:00 PM PDT
    DATE:  March 26, 2019TIME:  2:00pm PDT, 5:00pm EDT  Prostate cancer is the second most common form of cancer in males, affecting one in eight men by the time t...
    Loading Comments...
    Show Resources